Selected publications

Suvà ML*, Riggi N*, Stehle JC, Baumer K, Tercier S, Joseph JM, Suvà D, Clément V, Provero P, Cironi L, Osterheld MC, Guillou L and Stamenkovic I. Identification of cancer stem cells in Ewing’s sarcoma. Cancer Res. 2009, 69: 1776-1781.

Suvà, M-L*, Riggi N*, Janiszewska M., Radovanovic I., Provero P, Stehle J-C., Baumer K, Le Bitoux M-A., Marino D, Cironi L, Marquez VE, Clément V. and Stamenkovic I. EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res. 2009, 69:2911-2918.

Cironi L, Provero P, Riggi, N, Janiszewska M, Suva D, Suva ML, Kindler V and Stamenkovic I. Epigenetic features of human mesenchymal cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1 PLoSONE; 2009, 4:e7904.

Riggi N, Suvà ML, De Vito C, Provero P, Stehle JC, Baumer K, Cironi L, Janiszewska M, Petricevic T, Suvà D, Tercier S, Joseph JM, Guillou L, Stamenkovic I. EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells. Genes & Dev. 2010, 24:916-932.

Planche A, Bacac M, Provero P, Fusco C, Delorenzi M, Stehle JC and Stamenkovic I. Identification of prognostic molecular features in the reactive stroma of human breast and prostate cancer PLoSONE, 2011 6:e18640.

Mauti LA*, Le-Bitoux MA*, Baumer K, Stehle JC, Golshayan D, Provero P and Stamenkovic I. Myeloid-derived suppressor cells are implicated in regulating tissue permissiveness for tumour metastasis during murine gestation.J. Clin Invest, 2011 121:2794-2807.

DeVito C, Riggi N, Suvà ML, Janiszewska M, Horlbeck J, Baumer K, Provero P and Stamenkovic I. Let-7a is a direct EWS-FLI-1 target implicated in Ewing’s sarcoma development. PLoSONE, 2011, 6:e23592.

De Vito C*, Riggi N*, Cornaz S, Suva ML, Baumer K, Provero P, Stamenkovic I. A TARBP2-dependent miRNA expression profile determines cancer stem cell properties and provides candidate therapeutic reagents in Ewing sarcoma. Cancer Cell, 2012; 21:807-816

Janiszewska M*, Suvà ML*, Riggi N, Houtkooper RH, Auwerx J, Clément-Schatlo V, Radovanovic I, Rheinbay E, Provero P, Stamenkovic I. Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells. Genes & Dev. 2012; 26:1926-1944.

Cornaz-Buros S, Riggi N, DeVito C, Sarre A, Letovanec I, Provero P, Stamenkovic I. Targeting cancer stem-like cells as an approach to defeating cellular heterogeneity in Ewing sarcoma. Cancer Res., 2014; 74:6610-6622.

Dayer C and Stamenkovic I. Recruitment of Matrix Metalloproteinase-9 (MMP-9) to the fibroblast cell surface by Lysyl Hydroxylase-3 (LH3) triggers TGF-β activation and fibroblast differentiation. J. Biol. Chem., 2015; 290:13763-13778.